TI
DMTX

Turner Investments’s Dimension Therapeutics, Inc DMTX Stock Holding History

Turner Investments’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-30,100
Closed -$131K – 312
2016
Q4 		$131K Buy
+30,100
New +$160K 0.05% 238

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Turner Investments's DMTX Position: Q1 2017 in Review

Turner Investments sold out of Dimension Therapeutics, Inc (DMTX) in Q1 2017, closing a stake of 30,100 shares — an estimated $131K sold.

Turner Investments first reported a position in DMTX in Q4 2016 and held it in 1 quarter. The position peaked at $131K in Q4 2016. 47 funds tracked by Wall St. Rank hold DMTX as of Q1 2017.

  • Turner Investments reported no remaining Dimension Therapeutics, Inc position as of Q1 2017 after selling out during the quarter.
  • Turner Investments sold 30,100 Dimension Therapeutics, Inc shares in Q1 2017, an estimated $131K.
  • Turner Investments first reported a position in Dimension Therapeutics, Inc in Q4 2016 and held it in 1 quarter.
  • Turner Investments's Dimension Therapeutics, Inc position peaked at $131K in Q4 2016.
  • 47 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.